In this context, a quantification study of p75NTR‐ECD levels in CSF of patients with AD, MCI due to AD, FTD, and non‐neurodegenerative dementia was completed, but the results have not been released yet (ClinicalTrials.gov Identifier: NCT02946710). This evidence concerns the gene NGFR and Alzheimer disease.